Follistatin-344 1mg

 149,00

Grail Formula Quality
Follistatin-344 1 mg – High Purity Research Peptide.

Researched and independently verified with Liquilabs s.r.o. (Czechia).
Validated assay content 1.075 mg with purity greater than 99.8 percent.
Endotoxins below 0.001 EU per mg. No detectable microbial growth or heavy metals.

For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.


Product Overview

Follistatin-344 is a synthetic research peptide corresponding to a naturally occurring glycoprotein involved in regulatory signalling pathways related to cellular growth, differentiation and tissue regulation. In laboratory environments, it is studied for its interaction with activin-binding mechanisms and its role in growth-regulatory pathway modelling. This lyophilized 1 mg preparation supports controlled in vitro research focused on peptide–protein interaction dynamics and signalling modulation studies.


Peptide Overview

Follistatin was first identified in the late 1980s during research into regulatory proteins involved in follicle-stimulating hormone modulation. The 344–amino-acid isoform has since been utilised in preclinical research settings to investigate growth-regulation pathways, protein-binding dynamics and signalling balance within complex biological systems.

Due to its clearly defined molecular structure and strong protein-binding affinity, Follistatin-344 is frequently employed as a reference compound in laboratory models examining regulatory feedback mechanisms and peptide-mediated pathway control.


Historical Background and Scientific Context

From the late twentieth century onward, research into growth-regulatory proteins expanded rapidly as laboratories explored signalling molecules capable of modulating cellular differentiation and tissue development. Follistatin-344 has played a significant role in this field, serving as a key research tool in studies investigating activin–myostatin signalling pathways and regulatory protein interactions under controlled experimental conditions.


Mechanistic Focus in Research

  • Activin- and myostatin-binding pathway research
  • Growth-regulatory signalling modulation studies
  • Peptide–protein interaction analysis
  • Comparative structure–function evaluation
  • Controlled in vitro growth-regulation modelling

Analytical Verification (COA)

Independent Liquilabs analysis confirms full validation for Batch GF122025092. Key analytical results include:

  • Assay Content: 1.075 mg
  • Identification – Retention Time: 1.000
  • Identification – Spectrum: 983
  • Purity: greater than 99.8 percent
  • Endotoxins: below 0.001 EU per mg
  • Total Aerobic Microbial Count: not detected
  • Total Yeast and Mold Count: not detected
  • Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures, ensuring transparent documentation and complete batch traceability.


Research Applications

  • Growth-regulation and signalling pathway research
  • Protein–peptide interaction studies
  • Myostatin- and activin-related pathway modelling
  • Comparative regulatory protein evaluation
  • Controlled in vitro biochemical investigations

Grail Formula Quality

Every Grail Formula research peptide undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for low endotoxin levels, analytical consistency and reproducibility to support reliable scientific research outcomes.


When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.


Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity Follistatin-344 research peptide
Validated assay content 1.075 mg with purity greater than 99.8 percent
Retention time and spectral identification confirmed
Endotoxin levels below 0.001 EU per mg
No detectable microbial growth or heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products